PJP

Smart Beta Channel

Write A Prescription For This Pharma ETF

By Tom LydonJuly 10, 2017

Equity ETFs

How a New SCOTUS Ruling Could Affect Pharma ETFs

By Tom LydonJune 14, 2017

Equity ETFs

Drug Makers, Pharma ETFs Face a Tough Earnings Season

By Max ChenApril 24, 2017

Equity ETFs

Look to These Sector ETFs in Case of an Election Day Surprise

By Max ChenNovember 4, 2016

Equity ETFs

Finding Pharmaceuticals ETFs With Rebound Potential

By Tom LydonMay 4, 2016

Equity ETFs

The Best Performing ETFs Since the Financial Downturn

By Max ChenMarch 9, 2016

Featured

Major Pharma Merger Boosts ETFs

By Tom LydonOctober 29, 2015

Featured

Political Placebo: Pharma Regulation

By Tom LydonOctober 12, 2015

Featured

A Long-Term Healthcare Winner

By Tom LydonSeptember 24, 2015

Featured

A Powerful Pharma ETF

By Tom LydonAugust 3, 2015

Featured

M&A Activity Will Support Pharma ETFs Through Rising Rate Environment

By Tom LydonJuly 9, 2015

Equity ETFs

Teva/Mylan Deal Doesn’t Stir Pharma ETFs

By Todd ShriberApril 17, 2015

Equity ETFs

Pharma ETFs Boosted by Mylan’s Giant Offer for Perrigo

By Todd ShriberApril 8, 2015

Featured

No Surprise: Healthcare ETFs See Rapid Asset Growth

By Todd ShriberMarch 19, 2015

Featured

These ETFs Might Enjoy the Salix Takeover News

By Tom LydonFebruary 23, 2015

Featured

Small Percentage of PowerShares ETFs Expected to Distribute Cap Gains

By Tom LydonDecember 15, 2014

Featured

Winning: Smart Beta ETFs Keep Gaining Traction

By Todd ShriberDecember 2, 2014

Featured

Short Covering Could be Next Catalyst for Health Care ETFs

By Todd ShriberNovember 24, 2014